Department of Thoracic and Cardiovascular Surgery, Huashan Hospital, Affiliated with Fudan University, Shanghai 200040, China.
Department of Respiratory Endoscopy, Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China.
Oxid Med Cell Longev. 2022 Jul 19;2022:7288729. doi: 10.1155/2022/7288729. eCollection 2022.
Pulmonary ischemia reperfusion- (I/R-) induced dysfunction is a significant clinical problem after lung transplantation. In this study, we aim to explore the molecular mechanism of lung I/R injury (LIRI).
Bioinformatic analysis of gene involved in oxidative stress. A HUVEC oxygen glucose deprivation/reoxygenation (OGD/R) model and I/R mouse model were first established via I/R. The cellular proliferation, migration, reactive oxygen species (ROS), and parameters of lung injury were assessed via CCK-8, EdU staining, Transwell, cellular ROS kit, and H&E staining. We also confirmed related gene expressions and protein levels and the interaction between the tissue factor pathway inhibitor (TFPI) promotor and ZNF354C.
Bioinformatic analysis results showed TFPI contributed to oxidative stress. OGD/R caused a reduction in cell viability and migration, hypermethylation of TFPI, increased ROS, and downregulation of ZNF354C, TFPI, and DNA methyltransferases (DNMTs) in HUVECs. Besides, ZNF354C could directly bind to the TFPI promoter, enhance proliferation and migration, and inhibit ROS in OGD/R-induced HUVECs by upregulating TFPI. More importantly, we discovered that 5-Aza could reduce TFPI methylation, upregulate TFPI, and enhance the binding of ZNF354C to the TFPI promoter in LIRI. Furthermore, DNMT1 silencing could induce proliferation and migration and prevent ROS in OGD/R-induced HUVECs by upregulating ZNF354C. Additionally, we verified that ZNF354C could alleviate LIRI by preventing DNA methylation .
ZNF354C overexpression induced proliferation and migration, as well as suppressed ROS in OGD/R-induced HUVECs, and alleviated LIRI in mice by inhibiting TFPI promoter methylation to upregulate TFPI. Therefore, ZNF354C and TFPI methylation might be promising molecular markers for LIRI therapy.
肺缺血再灌注(I/R)引起的功能障碍是肺移植后一个严重的临床问题。在本研究中,我们旨在探索肺 I/R 损伤(LIRI)的分子机制。
涉及氧化应激的基因的生物信息学分析。首先通过 I/R 建立 HUVEC 氧葡萄糖剥夺/再氧合(OGD/R)模型和 I/R 小鼠模型。通过 CCK-8、EdU 染色、Transwell、细胞 ROS 试剂盒和 H&E 染色评估细胞增殖、迁移、活性氧(ROS)和肺损伤参数。我们还证实了相关基因表达和蛋白水平,以及组织因子途径抑制剂(TFPI)启动子和 ZNF354C 之间的相互作用。
生物信息学分析结果表明 TFPI 参与氧化应激。OGD/R 导致 HUVEC 细胞活力和迁移减少,TFPI 超甲基化,ROS 增加,ZNF354C、TFPI 和 DNA 甲基转移酶(DNMTs)表达下调。此外,ZNF354C 可以直接结合 TFPI 启动子,通过上调 TFPI 增强 OGD/R 诱导的 HUVEC 增殖和迁移,并抑制 ROS。更重要的是,我们发现 5-Aza 可以减少 TFPI 甲基化,上调 TFPI,并增强 ZNF354C 与 LIRI 中 TFPI 启动子的结合。此外,沉默 DNMT1 可以通过上调 ZNF354C 诱导 OGD/R 诱导的 HUVEC 增殖和迁移,并防止 ROS。此外,我们验证了 ZNF354C 通过抑制 TFPI 启动子甲基化来上调 TFPI,从而减轻 LIRI。
ZNF354C 过表达诱导 OGD/R 诱导的 HUVEC 增殖和迁移,并抑制 ROS,通过抑制 TFPI 启动子甲基化来上调 TFPI,从而减轻小鼠的 LIRI。因此,ZNF354C 和 TFPI 甲基化可能是 LIRI 治疗的有前途的分子标志物。